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Effects of messaging on public support for drug consumption rooms in Scotland, UK 
Abstract 
Background 
There is evidence to suggest that medically supervised drug consumption rooms (DCRs) may 
form part of responses to reduce drug-related harm. Although DCRs have been established 
globally, they are perceived by some to be a controversial approach in the UK, and 
Government has repeatedly rejected proposals to establish one in Glasgow, Scotland. As 
public support is an important component of policy development and enactment, we sought to 
investigate the effects of different types of message framing on public support for DCR. 
 
Methods 
We undertook a cross-sectional online study with a randomised design, conducted with a 
nationally representative sample. Participants were randomised to one of six message 
conditions comprising combinations of four components. All conditions included i) a basic 
description of a DCR, and conditions included combinations of ii) factual information; iii) pre-
emptive refutation of common public concerns about DCR; and/or iv) a sympathetic narrative 
describing a mother whose son died from a heroin overdose. After reading each message, 
participants completed a bespoke measure assessing support for DCR. Data were analysed 
using ANCOVA. 
 
Results  
Complete data were obtained from 1591 participants (50.3% Female; mean age 44.9 ± 16.1 
years). Compared to reading a basic description of DCR alone, there was greater support for 
DCR in participants receiving the refutation (p < .001); sympathetic + factual (p < .05); and 
sympathetic + factual + refutation (p < .001) message conditions. Presenting factual or 
sympathetic messages alone were not associated with increased support.  
 
Conclusion 
Our findings suggest that public support for DCRs is not improved through communication of 
factual statements outlining potential benefits of the intervention alone. Advocates seeking to 
foster public support, and thus influence policy making, should also consider communication 
campaigns that address common concerns that the public might have about DCRs, and 
present the intervention in relation to potential benefits that they hold for people indirectly 
affected by drug-related harm. 
 
 
Keywords: drug consumption rooms; drug policy; agenda setting; public communication
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Introduction 
 
Drug-related mortality and morbidity are significant public health concerns in the UK. Despite 
provision of evidence-based treatment and harm reduction interventions, there are historically 
high levels of drug-related deaths, and people who inject drugs (PWID) experience high levels 
of other long-term conditions (Lewer, Freer, et al., 2019; Lewer, Tweed, Aldridge, & Morley, 
2019; Maisa, et al., 2019; McAuley, Palmateer, et al., 2019; National Records of Scotland, 
2019; Northern Ireland Statistic Research Agency, 2019; Office for National Statistics, 2019; 
Trayner, et al., 2020). Rapid increases in HIV prevalence in PWID have been recently 
recorded in the Scottish (UK) city of Glasgow (McAuley, Palmateer, et al., 2019), and in 
Hepatitis C virus (HCV) prevalence in other regional areas of Scotland (UK) (McAuley, Yeung, 
et al., 2019). In 2018, 10.8% of clients sampled from injecting equipment services in Glasgow 
city centre tested positive for HIV, representing the largest documented HIV outbreak among 
this population in the UK for 30 years (McAuley, Palmateer, et al., 2019). Infections were 
associated with homelessness, incarceration, and, in particular, stimulant injecting (McAuley, 
Palmateer, et al., 2019). Similarly, public drug injection, a risk factor for blood borne viruses 
(BBV), soft tissue infections, and drug overdose, was reported by 16.0% of PWID in Scotland, 
and 47.0% in Glasgow city centre (Trayner, et al., 2020).  
 
A number of individual and structural interventions have been proposed as part of the 
development of a co-ordinated strategy to reduce these drug related harms in Glasgow 
(Trayner, et al., 2020; Tweed, Rodgers, Priyadarshi, & Crighton, 2018). Alongside other 
intervention and systems-improvement activities, a case was developed for the introduction of 
a drug consumption room (DCR) (Tweed & Rodgers, 2016). These are facilities, typically 
located in health-care settings, that allow the consumption of pre-obtained drugs in safer and 
more hygienic conditions, through supervision by medically-trained staff and provision of clean 
injecting equipment (ACMD, 2016; European Monitoring Centre for Drugs and Drug Addiction, 
2018; Jauffret-Roustide & Cailbault, 2018). In Glasgow, proposals were developed for a DCR 
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which would primarily target PWID with experience of homelessness and public injecting 
(Tweed & Rodgers, 2016). However, the introduction of DCRs in the UK requires a new legal 
framework, as the operation of DCRs, including service users’ possession of controlled drugs, 
is subject to a range of (potential) criminal and civil law offences (Fortson & McCulloch, 2018). 
Despite support from policy actors including local cross-sector partnerships, the Scottish 
Government, the Advisory Council on the Misuse of Drugs (ACMD), Members of the UK 
Parliament, and sections of national media, DCRs have not received support from the UK 
government (summarised in Atkinson, McAuley, Trayner, and Sumnall (2019)). Indeed, prior 
to a national summit on responses to drug-related deaths held in Glasgow in February 2020, 
the UK Minister with portfolio responsibility for drugs policy described discussion of DCRs as 
a ‘distraction’ (BBC, 2020). 
 
Despite operating in around 100 sites across 10 countries, in the UK DCRs are seen by some 
as a ‘controversial’ intervention (Atkinson, et al., 2019; Home Office, 2017; Lloyd, Stöver, 
Zurhold, & Hunt, 2017). Published evidence on their effectiveness is relatively limited 
(Kennedy, Karamouzian, & Kerr, 2017; Pardo, Caulkins, & Kilmer, 2018), particularly when 
delivered in the context of other harm reduction interventions. However, there is sufficient 
evidence from international implementations to support DCR pilots, in order to better 
understand their impact in areas with high levels of drug-related harm, such as Glasgow 
(Caulkins, Pardo, & Kilmer, 2019; Tweed, et al., 2018). 
 
In a recent analysis of news-media reporting of the proposals to introduce a DCR in Glasgow, 
we found that although a majority of articles (67%) positively represented the intervention, 
they were presented in ways that reflected broader and more complex public discourses about 
drug use and PWID, national politics, and the purpose and intent of harm reduction and drug 
treatment, particularly with regards to abstinence (Atkinson, et al., 2019). Research evidence 
on DCR and targeted harms were framed, contested, and utilised in ways that revealed these 
underlying motivations, and it was notable that media reporting rarely included the voices of 
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the intended beneficiaries, PWID. This work also found there was misunderstanding about the 
aims of DCR, and media frequently reproduced stigmatising and moralising narratives.  
 
International studies, including those conducted in Scotland (Trayner et al., (2020)), have 
consistently found a high degree of willingness of PWID to use DCRs, particularly those most 
at-risk of drug-related harm (e.g. Bouvier, Elston, Hadland, Green, and Marshall (2017); Butler, 
Chapman, and Terry (2018); Hunt, Lloyd, Kimber, and Tompkins (2007)). However, there has 
been less research investigating public attitudes and support for the introduction and operation 
of DCR, and little conducted in the UK (Potier, Laprévote, Dubois-Arber, Cottencin, & Rolland, 
2014). Work in Australia, Canada, and Germany has suggested that despite some initial 
resistance, once DCRs were introduced, public and local business support for the intervention 
increased, with little change in the proportion of those strongly opposed to the facilities (Cruz, 
Patra, Fischer, Rehm, & Kalousek, 2007; Potier, et al., 2014; Salmon, Thein, Kimber, Kaldor, 
& Maher, 2007; Strike, et al., 2014). In countries currently without sanctioned DCRs, the limited 
research available suggests that the public may not favour their introduction. An opinion 
survey conducted to coincide with an unsuccessful earlier attempt to introduce a DCR in the 
city of Brighton and Hove (UK) in 2013 showed that the majority of a nationally representative 
sample of the British population were opposed to the intervention (YouGov, 2013). Similarly, 
only 29% of a nationally representative sample of US adults (data collected in 2017) supported 
the approach, with positive responses dependent upon age, political preference, employment 
status, and lower levels of stigmatising attitudes towards people who use drugs (PWUD) 
(McGinty, Barry, et al., 2018). Further examination of the strength of agreement for arguments 
in favour or opposition to DCR in this sample found that the most highly rated opposing 
arguments were that running DCR were a poor use of public funds, or that they encouraged 
people to break the law and use controlled drugs (Barry, et al., 2019). In contrast (but still 
receiving less support than all opposing arguments), the most favoured arguments in support 
of DCR were that they were a better alternative to arresting people who use opioids, that they 
would reduce BBV transmission, and that they would reduce healthcare related costs. 
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Arguments in favour of DCRs, such as reducing public drug use, or providing a safe site where 
PWUD would be treated with dignity and respect, received little support (Barry et al., 2019). 
These findings mirrored those of our analysis of UK media reporting (Atkinson et al., 2018). 
 
Low public support presents a significant barrier to the introduction of drug policy that might 
have public health benefits (Jauffret-Roustide & Cailbault, 2018; Lloyd, et al., 2017; Smith, 
Favril, Delhauteur, Vander Laenen, & Nicaise, 2019). Whilst public support is only one form of 
‘evidence’ utilised (and created) in complex policy development processes (Cairney, 2016; 
Lancaster, Ritter, & Stafford, 2013; Lancaster, Sutherland, & Ritter, 2014; Oliver & de Vocht, 
2015; Stevens & Zampini, 2018), it is still important (Burstein, 2003). Reviews of approaches 
that communicate evidence on policy effectiveness have shown that these can lead to 
changes in public beliefs that lead to more supportive attitudes towards that policy, including 
some substance use (alcohol) policies (Reynolds, Stautz, Pilling, van der Linden, & Marteau, 
2020). However, in relation to controlled drug policy, this is complicated by the strong moral 
and political positions taken towards these types of substances and the people who use them, 
leading to differential public and political support for response preferences, and prioritisation 
of those populations and individuals who are perceived as ‘deserving’ of support (Brown & 
Wincup, 2019; da Silveira, de Tostes, Wan, Ronzani, & Corrigan, 2018; Hopwood, Brener, 
Frankland, & Treloar, 2010; Kelly, Dow, & Westerhoff, 2010; Lloyd, 2013; Radcliffe & Stevens, 
2008; Sattler, Escande, Racine, & Goritz, 2017; Stevens, 2018; Stevens & Zampini, 2018). 
This means that simple presentation of evidence on the effectiveness or cost-effectiveness of 
drug policy approaches may not be sufficient to foster supportive attitudes.  
 
Message framing, the way in which information is selected and presented to audiences, 
influences how people develop a particular conceptualisation of an issue or reorient their 
thinking about it, particularly for those issues that are unfamiliar, and/or where audiences hold 
ambiguous attitudes (Chong & Druckman, 2007). In a study examining the effects of different 
message framing on public attitudes towards take-home naloxone policies in the USA, it was 
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found that presenting factual informal about naloxone, refutation of common concerns about 
naloxone provision, or a sympathetic narrative about a mother whose daughter died of an 
opioid overdose were all associated with increased policy support (Bachhuber, McGinty, 
Kennedy-Hendricks, Niederdeppe, & Barry, 2015). Presenting factual information alongside 
the sympathetic narrative was found to be the most effective approach, as the combination of 
an emotional appeal humanising the policy proposals, and factual information drawing 
attention to contextual/environmental determinants of drug-related harm may have countered 
attribution of personal blame, leading to greater support (Bandara, McGinty, & Barry, 2020; 
Gross, 2008). The importance of message framing has been confirmed in other studies, 
including those investigating public support for criminal justice reform, public stigma towards 
PWUD, and belief in the effectiveness and willingness to pay for drug treatment (Ashford, 
Brown, & Curtis, 2018; Bandara, et al., 2020; Hopwood, et al., 2010; Kennedy-Hendricks, 
Barry, & McGinty, 2016; McGinty, Goldman, Pescosolido, & Barry, 2015; Robinson & Adinoff, 
2018). 
 
In this study we adapted the methodology of Bachhuber and colleagues (2015) to investigate 
the effects of message framing on public support for the introduction of DCRs in a 
representative sample of the Scottish population. We hypothesised that presentation of a 
narrative that combined a summary of evidence that DCR could reduce drug-related harms in 
Scotland with a sympathetic account of how a drug-related death affected a family, would lead 
to greater support for DCR, compared with a description of the intervention alone. Considering 
that UK media reports often misrepresented the aims of DCR (Atkinson, et al., 2019), we 
further hypothesised that the inclusion of information that refuted common misconceptions 
about DCR would also be associated with higher levels of support.  
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Methods 
 
Design 
The study utilised a cross-sectional randomised design, and participants completed an 
anonymous online survey.   
 
Participants 
Adult members of the public (n = 1591) were recruited from a nationally representative 
research panel (provided by Qualtrics, Provo, UT, USA) between 6th and 29th March 2020. An 
a priori power calculation (G*Power 3.1; Faul, Erdfelder, Lang, and Buchner (2007)) to detect 
a medium effect size (f = 0.25; power 0.95), estimated a minimum sample size of 413 was 
required. Inclusion criteria were people who were currently living in Scotland, and aged over 
18 years. These two criteria were assessed through demographic profiling attributes provided 
by participants to the panel administrators, and checked through screening questions included 
in the online survey. The sample was representative of the population of males and females 
aged 18+ in Scotland. Participants received an invitation email from the panel provider inviting 
them to take part in the research. The email did not specify the research topic, only that the 
survey was for research purposes, how long it took to complete, and the compensation 
available (small monetary and non-monetary rewards managed by the panel provider). 
Clicking the included link took them to an online survey hosted on the Qualtrics platform 
(Qualtrics, Provo, UT, USA) where full study information was provided, and consent obtained.  
 
Materials 
Four message components were written in accordance with the approach of Bachhuber and 
colleagues (2015), and participants were randomised to receive one of six types of message 
combination (see below). The full text of message elements are provided in Supplementary 
Material S1. As we could not assume that participants had prior understanding of a DCR, a 
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description of the service was included in all message combinations, and this was based on 
the proposed Glasgow model of delivery (Tweed & Rodgers, 2016): 
 
Drug consumption rooms (DCRs), also known as supervised injection facilities or supervised 
consumption facilities, are designated places that legally permit the injection of drugs (or other 
forms of consumption), including those that are purchased illegally, under the supervision of 
medically-trained staff. These facilities also provide sterile injecting equipment (such as 
needles and syringes), to reduce behaviours such as syringe sharing and provide access to 
health and social care staff. Some facilities also support people to enter drug treatment to help 
them deal with their drug use. UK drug laws do not currently permit the operation of DCR, and 
therefore none are currently in operation in the UK. 
 
Other content was derived from published evidence, including local need assessments, 
reviews of evaluation and economic studies: 
 
The message components were: 
1) DCR description only (presenting the DCR description above);  
2) Factual information (presenting evidence on safety and (cost) efficacy of DCR in preventing 
overdose death and infection) (European Monitoring Centre for Drugs and Drug Addiction, 
2018; Kennedy, Karamouzian, & Kerr, 2017; Pardo, Caulkins, & Kilmer, 2018).  
3) Pre-emptive refutation (providing counterarguments to three common ethical and moral 
concerns around DCR identified in our previous media analysis (Atkinson, et al., 2019); i) that 
they encouraged drug use and prevent recovery, ii) that they pose a public disorder/safety 
threat (e.g. discarded injecting equipment, crime and disorder around the site), and iii) that 
they are a poor or inappropriate use of public (‘tax payers’) money);  
4) Sympathetic narrative (text about a mother whose son died from a heroin overdose. This 
text was based on the structure of the narrative presented in Bacchuber et al., (2015), but 
adapted from three case studies published in the NHS Greater Glasgow and Clyde report 
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Taking Away the Chaos (2016), which presented a health and social care needs assessment 
of public drug use in the region (Tweed & Rodgers, 2016)).    
 
The six message combinations are listed below, and message components were arranged to 
form a coherent narrative. All combinations included the DCR description: 
 
1. DCR description (hereafter described as the basic condition); 
2. Factual information (factual);  
3. Factual information + pre-emptive refutation (factual + refutation); 
4. Sympathetic narrative (sympathetic); 
5. Sympathetic + factual (sympathetic + factual); 
6. Sympathetic + factual + pre-emptive refutation (sympathetic + factual + refutation) 
 
We created a bespoke primary outcome measure assessing support for DCR (hereafter 
support for DCR). This comprised 25 items scored on a Likert scale (1 Strongly disagree to 5 
Strongly agree, some items were reverse scored), with higher total scores representing 
greater support for DCR (see Supplementary Material S2). Questions were based on previous 
attitudinal research undertaken in Sydney (Australia), the US, and Vancouver (Canada) 
assessing public support for DCR (Barry, et al., 2019; Strike, et al., 2014; Thein, Kimber, 
Maher, MacDonald, & Kaldor, 2005). Example items included Drug consumption rooms will 
increase drug users’ contact with health and social workers; Drug consumption rooms will 
reduce infectious diseases such as HIV and Hepatitis C among drug users; Areas that have a 
drug consumption room operating will be less desirable to live or run a business in; Drug 
consumption rooms are not a good use of public funds. In this study, Cronbach’s  = 0.94, 
indicating a high level of internal consistency. 
 
Additional measures 
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Demographic questions included age, gender, education, ethnicity, and employment. 
Participants were asked about frequency of their media use (news, entertainment, and social 
media), and voting preference (main UK political parties; recoded into left; right; centre parties 
for analysis).  
 
Bespoke measures were created from existing tools, to assess participants’ attitudes to 
homelessness, and PWUD. Attitudes towards people who are homeless were assessed 
through three questions taken from the Scottish Social Attitudes Survey General Attitudes to 
Homeless Module (The Scottish Government, 2006). These were Most homeless people have 
just been unlucky in their lives; Most homeless people could find somewhere to live if they 
really tried; Many people say they are homeless just to try and get a house from the council. 
Questions were scored on a Likert scale (1 Strongly Disagree to 5 Strongly Agree, with 
appropriate reverse scoring) with higher total scores representing more positive attitudes. In 
the present study, Cronbach’s  = 0.61, indicating an acceptable level of internal consistency. 
 
Attitudes towards PWUD were assessed through 18 questions taken from a public attitudes 
measure, originally adapted from the UK Department of Health’s Attitudes to Mental Illness 
survey (Singleton, 2010), and utilised in the 2016 Scottish Government’s Public Attitudes 
Towards People with Drug Dependence and People in Recovery survey (The Scottish 
Government, 2016) (hereafter referred to as attitudes to people in recovery). Questions were 
scored on a five point Likert scale (1 Strongly Disagree to 5 Strongly Agree, with appropriate 
reverse scoring) and assessed attitudes towards people with a history of drug dependence 
(e.g. Parents should not let their children play with the children of someone with a history of 
drug dependence; People with a history of drug dependence are too often demonised in the 
media; Increased spending on helping people overcome drug dependence is a waste of 
money). Principal components analysis identified four factors (blame and intolerance; 
sympathy and care; fear and social exclusion; acceptance and integration) (Singleton, 2010); 
but as the scale score was used as a covariate in the current analysis, only the total score 
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was utilised. Higher total scores represented more positive attitudes. In the present study, 
Cronbach’s  = 0.91, indicating a high level of internal consistency.  
 
Participants were also asked to give a brief substance use history (lifetime and last year use 
of a number of substances); and to indicate if i) they; and ii) a family member/close friend, had 
ever received drug treatment (coded 0 = no; 1 = yes). They also self-rated their knowledge of 
the reasons why some people develop problems with substances and others do not; and self-
rated their knowledge of DCRs prior to the survey. Both items were scored on a 10-point scale. 
Finally, participants were asked to indicate if they had seen a media report about DCRs in the 
last 6 months, and if so, whether they judged these to be in favour, opposed to, or balanced 
towards the introduction of DCRs. 
 
Procedure 
 
The online survey comprised three sections, and took between 8-15 minutes to complete 
depending upon which messaging condition was presented. A pilot study utilising a 
convenience sample (n = 180) recruited from the authors’ social media networks was used 
prior to panel survey recruitment in order to ascertain completion rates (85%), completion time 
(range: 10-15 minutes), and unusual data response patterns (e.g. missing responses to the 
primary outcome assessment). No subsequent amendment of study materials was required. 
After reading the study information and providing consent, participants first completed 
demographic questions. Participants were then randomised to receive one of the six 
messaging conditions described above. After presentation of the message, they were asked 
to confirm that they had read it (lack of confirmation led to survey termination; no responses 
were withdrawn in this way), and to complete the primary outcome measure. Participants were 
then asked to complete the remaining questions. Soft-launch of the survey (n = 100 
participants) indicated a median completion time of 9.5 minutes, and this was used as a 
survey-attention indicator. Participants who subsequently completed the survey in under 4.75 
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minutes (one half of the median time), indicating possible lack of attention, were automatically 
excluded from the full launch (n = 0). 
 
The research was approved by Liverpool John Moores University Research Ethics Committee. 
Panel recruitment proceeded in accordance with the International Chamber of Commerce 
Code on Market, Opinion and Social Research and Data Analytics.  
 
Statistical analysis 
 
The primary analysis was undertaken using ANCOVA with planned contrasts (reference 
category = basic message condition). The dependent variable was support for DCR score, 
with message condition as the independent variable. Covariates were scores for prior self-
rated knowledge about substance use and DCRs, attitudes towards people in recovery, 
attitudes towards people who are homeless, and personal experience of treatment or knowing 
someone who had received treatment. These covariates were chosen on the basis of previous 
research showing that people can become more entrenched in beliefs about policy 
effectiveness when faced with evidence that supports or challenges pre-existing views, and 
that stigma towards PWUD, and familiarity with drug-related topics, including personal 
experience are important predictors of support for DCR and other drug treatment interventions 
(e.g. Barry, et al. (2019); Kennedy-Hendricks, et al. (2017); Matheson, et al. (2014); McGinty, 
Barry, et al. (2018); Reynolds, et al. (2020); Zarkin, Cates, and Bala (2000)). Attitudes towards 
people experiencing homelessness was specifically included as a covariate because this 
population has been identified as one of the main primary beneficiary group of the Glasgow 
DCR (Tweed, et al., 2018). Furthermore, substance use in this population has been shown to 
further exacerbate public stigma, and social attitudes surveys indicate sympathy towards 
affected groups in the Scottish general population depends on demographic characteristics 
(Alexandrescu, 2020; Atkinson, et al., 2019; The Scottish Government, 2006). Preliminary 
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analysis showed all covariates were independent of message presentation condition effects 
(see Table 1).   
 
An exploratory hierarchical linear regression analysis was then undertaken with support for 
DCR score as the dependent variable in order to investigate individual-level predictors of 
support. Message condition was entered into step 1 (reference category = basic); 
demographics (age, gender, education) in step 2; and political orientation, exposure to DCR 
in the media, self-rated knowledge about substance use and DCR, attitudes towards people 
in recovery, attitudes to people who are homeless, and personal experience of treatment or 
knowing someone who had received treatment into step 3. 
 
Alpha was set at 0.05, and all analyses were undertaken with jamovi (jamovi project (2020) 
v1.2.9.0).  
 
Results 
Sample demographic and other descriptive data are presented by randomised condition in 
Table 1. Randomisation to condition was judged to be successful, as conditions were 
equivalent on all variables of interest, except use of crack cocaine, where a significantly higher 
number than expected of the sympathetic + factual + refutation group reported lifetime use 
(7.9% compared with a sample mean of 4.3%).  
 
INSERT TABLE 1 HERE 
 
The overall ANCOVA model was significant (F (11,1489) = 170.594; p < .001 (Table 2)). The 
covariates, attitudes to homelessness (F (1,1489) = 21.354, p < .001); attitudes to recovery (F 
(1,1489) = 1061.353, p < .001); and self-rated knowledge about DCRs (F (1,1489) = 14.594, 
p < .001) were all significantly related to DCR support score. More positive attitudes were 
associated with greater support for DCRs, whilst lower self-rated knowledge about DCRs prior 
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to participation was associated with greater support after message exposure. After controlling 
for model covariates, there was a significant effect of the message condition on support for 
DCRs (F (5,1489) = 5.555, p < .001). Analysis comparing the different conditions showed that 
compared to the basic condition there was greater support for DCRs in the factual + refutation 
(p < .001); sympathetic + factual (p = .012); and sympathetic + factual + refutation (p < .001) 
message conditions. Examining coefficients, the factual + refutation message condition was 
associated with the highest support, followed by sympathetic + factual + refutation; and 
sympathetic + factual. The sympathetic (p = .645) and factual (p =.05) conditions were not 
associated with support for DCRs. 
 
INSERT TABLE 2 HERE 
The regression analysis predicting support for DCRs and model parameters are presented in 
Error! Reference source not found.. The final model was statistically significant (R2 = .679; 
F (19,570) = 63.56 (p < .001)). In the first step (inclusion of message condition only), none of 
the predictors were significant. In the second step (inclusion of demographics), older age ( = 
.095, p < .05) was associated with greater support for DCRs. In the final step, compared to 
the basic message condition, the factual + refutation ( = .302, p < .05) and sympathetic + 
factual + refutation ( = .281, p < .001) conditions were associated with greater support for 
DCRs. Other significant predictors included older age ( = .149, p < .001), more positive 
attitudes to people in recovery ( = -.732, p < .001) or who are homeless ( = .078, p < .05), 
lower self-reported knowledge about drug use ( = -.083, p < .01) and recalling fewer balanced 
( = -.281, p < .001) or oppositional ( = -.427, p < .001) media representations of DCR 
compared to supportive representations. Political orientation towards centre parties compared 
with those that are left-wing was associated with less support for DCRs ( = -.220, p < .05).  
 
INSERT TABLE 3 HERE 
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Discussion 
We examined the effects of random presentation of different messages about DCRs on public 
support for the intervention in a nationally representative sample. We found that compared to 
presentation of a basic description of DCRs, and controlling for a number of confounding 
variables, presentation of i) factual information about the potential benefits of the intervention 
with refutation of arguments frequently presented in UK media opposing the intervention; ii) 
factual information with a sympathetic narrative about a family affected by a drug-related 
death; and iii) a combination of the sympathetic narrative, factual information, and refutation 
of opposing arguments, were all associated with increased support for DCRs. Our study 
hypotheses were supported, although unlike the work of Bachhuber and colleagues (2015), 
who investigated naloxone policies, and upon which our methodology was based, we found 
that presentation of factual information or a sympathetic narrative alone were not associated 
with increased support. 
 
Our findings have a number of implications for activities that aim to generate public support 
for DCRs, and in turn contribute to policy change. These results suggest that advocates 
wishing to build support for DCR should emphasise benefits of DCRs for PWID, challenge 
misconceptions about the intervention, as well as incorporate sympathetic experiences of 
those indirectly affected by drug-related harm, such as family members. Recent UK news 
media reporting on proposals to implement a DCR in Glasgow prioritised quantitative 
evidence, and there was a lack of inclusion of the experiences of PWID and others affected 
by drug related harms (Atkinson et al., 2019). Presentation of quantitative (‘factual’) evidence 
can lead to increased policy support, but confirmation bias can lead to selective dis/crediting 
of evidence in accordance with pre-existing cultural, moral, and socio-political beliefs or 
personal behaviours (e.g. substance use) that are relevant to the policy question 
(Baumgaertner, Carlisle, & Justwan, 2018; Reynolds, et al., 2020). Previous work has shown 
that policy advocacy activities may be most persuasive when they combine relevant scientific 
evidence with narratives that acknowledge the public’s ethical concerns and have high 
 17 
emotional appeal that puts a ‘human face’ on complex societal issues, including how the lack 
of a policy response affects people (Jones, McBeth, & Shanahan, 2014; Oliver & Cairney, 
2019; Reynolds, et al., 2020; Shanahan, McBeth, & Hathaway, 2011). This may suggest one 
reason why the combination of factual information with a sympathetic narrative was associated 
with increased support for DCR in this study. Whilst we did not assess it, sympathetic 
narratives can elicit emotions that lead audiences to adopt attitudes and beliefs that are similar 
to those of the character that they identify with (Bachhuber, et al., 2015; Correa, Stone, Stikic, 
Johnson, & Berka, 2015; Murphy, Frank, Chatterjee, & Baezconde-Garbanati, 2013). Morality 
is an important component of successful narrative strategies, and this can be used to help 
shape relevant calls-to-action (Jones & Crow, 2017). In our study, and in keeping with similar 
research (Bachhuber, et al., 2015; Bandara et al., 2020), when combined with clear health 
and economic information (e.g. the number and economic costs of drug-related deaths and 
infections), the account of parental distress may have provided a moral focus that suggested 
a relevant policy response, i.e. introduction of a DCR. In the drugs policy field, biographical 
and moral narratives are often drawn upon by policy makers and other policy actors such as 
the media, to frame policy agendas or promote preferred responses. However, these have 
typically taken a narrow and selective perspective (e.g. ‘decline and redemption’ arcs), that 
emphasises vulnerability and deficit in PWUD (Pienaar & Dilkes-Frayne, 2017; valentine, et 
al., in press), and the moral framing of recovery and abstinence in UK drugs policy (Duke, 
2013; Stevens, 2018) may be at odds with a harm reduction service such a DCR (Atkinson et 
al., 2019; Lloyd et al., 2017). This suggests that there needs to be careful consideration of the 
choice of subject in such public communications narratives. In the current study we did not 
include a sympathetic message component depicting the potential benefits of a DCR for 
PWID. Comparing presentation of family members and primary intervention target groups will 
be important to examine in follow up studies, but the latter may be less likely to evoke a 
sympathetic response in audiences. As noted by Bandara and colleagues (2020), depiction of 
‘active’ or ‘untreated’ substance use is associated with higher levels of stigmatising attitudes, 
and this interacts with other subject characteristics (e.g. gender, ethnicity, socioeconomic 
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status), leading to a lower likelihood of audience-subject identification (Kennedy-Hendricks, et 
al., 2016; McGinty, et al., 2015). Furthermore, an experimental manipulation that led to 
decreased stigmatising attitudes towards PWUD, did not lead to a corresponding increase in 
public support for treatment policies that required public spending (McGinty et al., 2015). 
 
Importantly, we found that the presentation of factual information or a sympathetic narrative 
alone were not associated with increased support, compared to the basic description. This 
contrasted with the findings of Bachhuber and colleagues (2018) who found that all message 
conditions increased support for specific naloxone policies. Our study was sufficiently 
powered, and the content of the two message conditions was similar between the two studies, 
although we included additional economic information in our factual condition. Those authors 
found that whilst exposure to factual information increased policy support, without a mitigating 
effect of a refutation message, it also increased negative beliefs about naloxone, such as that 
it would encourage opioid use or would not be effective in preventing overdose. However, we 
did not find any associations between policy support and the factual or sympathetic conditions 
when examining supportive and oppositional beliefs about DCR separately (Supplementary 
material S3). It is therefore uncertain why there were differences between the two studies, 
although they might be related to study components such as the policy topic, samples (US vs 
UK), or analytical strategies used (i.e. dichotomised measures of support for different naloxone 
policies vs a linear scale of support for one policy). A further consideration around provision 
of factual information is that in policy areas with a limited or emerging evidence base, or where 
there have been no relevant studies conducted in target geographies, it may be difficult to 
provide direct evidence of benefit (Caulkins, et al., 2019), or audiences may have been 
exposed to competing narratives (Atkinson, et al., 2019; Home Office, 2017; Jauffret-Roustide 
& Cailbault, 2018). Therefore, the inclusion of refutation messages might be important, as they 
not only counter emerging beliefs about unintended consequences of a policy (e.g. DCRs 
encourage drug use and law breaking), but might also inoculate against weaker oppositional 
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arguments in the future (McGinty & Barry, 2020; McGinty, Pescosolido, Kennedy-Hendricks, 
& Barry, 2018). 
 
Reflecting upon possible practical application of our work, a number of campaigns have been 
developed that aim to change public narratives around substance use, including work with 
media professionals. Recent examples include the Australian Overdose Lifesavers 
(https://overdoselifesavers.org/) and Lives of Substance (Fraser, et al., 2016) initiatives, and 
the US Changing the Narrative project (https://www.changingthenarrative.news/). Activities 
include the promotion of a ‘person-first’ language (Botticelli & Koh, 2016); explanations of 
substance use and its potential consequences that move beyond narratives focussed on 
individual choice;  highlighting structural barriers to treatment and support; and the provision 
of advice and guidance on reporting, including access to expert sources including people with 
lived experience. To the best of our knowledge, there have been no evaluations of campaigns 
such as these on the public’s drug policy preference or actual policy change, nor consideration 
of how communication activities are influenced by the media environment in which they are 
delivered (also see McGinty and Barry (2020)). A relevant body of research investigating 
influences on public attitudes in related fields (e.g. HIV, mental health) is more developed, and 
although still limited, highlights additional societal norms (and structures) that influence public 
attitudes and behaviour (e.g. Clement, et al. (2013); Corrigan, Morris, Michaels, Rafacz, and 
Rusch (2012); Stangl, Lloyd, Brady, Holland, and Baral (2013)). This work suggests that whilst 
public communications (and other activities) are important, these are unlikely to be effective 
without simultaneously addressing wider contextual and cultural factors. Substance use is 
newsworthy, and is often reported through ‘drug scare’ narratives, in which PWUD are 
presented as dangerous and criminal, and status quo policy responses of law and order are 
prioritised (Atkinson & Sumnall, in press; Bright, Bishop, Kane, Marsh, & Barratt, 2013; 
Forsyth, 2012). Such reporting is more common in populist sources, with high readership and 
public reach, and as such, may be more influential in determining overall public attitudes 
(Atkinson and Sumnall, in press; Atkinson et al., 2019). Moreover, there is declining news 
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readership in countries such as the UK (Ofcom, 2019), and set within a context of reduced 
revenue, time pressures and increased competition within- and between newsrooms, and 
along with declining public trust in media, and prominence of belief-reinforcing social media 
‘echo-chambers’ (Barberá, Jost, Nagler, Tucker, & Bonneau, 2015; McConnell, 2016; Saltzis 
& Dickinson, 2008; Vosoughi, Roy, & Aral, 2018), news stories and particular drug narratives 
are often reproduced, meaning that attempts to change narratives and foster support for a 
particular policy approach may face additional obstacles. However, access may be easier to 
establish at local level, and with national news stories often being initiated within the local 
media (Atkinson & Sumnall, in press; Forsyth, 2012), establishing relationships with local news 
outlets and journalists is an important component of advocacy.   
 
There were several limitations in this study, some of which are acknowledged here as they 
are also relevant for understanding practical interpretation. Although we presented a 
description of a DCR and asked participants to self-rate their knowledge about DCRs, it cannot 
be assumed that there was measurement invariance, or that participants fully understood how 
the intervention would operate in practice or what the health and social care aims are. In our 
analysis of UK media discussions of DCRs (Atkinson et al., 2019) we noted that DCRs were 
often presented in opposition to more traditional drug treatment and harm reduction 
approaches,  or presented alongside descriptions of heroin assisted treatment, and the two 
were sometimes conflated, so prior exposure to such articles may have led to some confusion 
over objectives of the intervention. However, in our basic description of DCRs, which formed 
part of all message conditions, we tried to present a clear overview of services that could be 
provided through a DCR, and considering potential confusion about facilitating access to drug 
treatment (also highlighted in the study of Barry, et al. (2019)), included this as an intervention 
objective. Message conditions were also of different lengths, and it took less time for 
participants to read the basic message than others. We tried to control for this by ascertaining 
whether respondents had read and understood the message they were presented with, but it 
remains that attentional effects could have affected responses. Longer messages may have 
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required greater attention, and consequently differences in message valence could have led 
to greater salience which would affect agreement scores. Follow up studies should therefore 
attempt to include messaging conditions of similar length and affective quality. Consideration 
of message format, length, and frequency of presentation is important with respect to the 
practical applications of this research. Public communication campaigns with persuasive intent 
typically utilise a combination of different communicators, message formats, lengths, and 
platforms (e.g. video, written, audio), with multiple audience exposures (e.g. Harrington, 
Helme, and Noar (2015)). As discussed above, these campaigns also compete with existing 
media narratives on substance use and the people who use them. Hence, written, single-
exposure strategies that show efficacy in experimental research such as this may therefore 
not necessarily be effective in fostering sustained support in public communication campaigns. 
Finally, although our sample was nationally representative with respect to age and gender, we 
recruited from an online panel survey, and participants may therefore differ from the Scottish 
general population with respect to important factors such as media engagement, 
understanding of drugs issues, and support for public funding of drug treatment more 
generally. Similarly, we do not know if oversampling of residents in urban areas such as 
Glasgow occurred. As the majority of public discussions of DCRs in the UK have focused on 
plans to introduce a service in this city, residents may have had differential support compared 
to other parts of the country. 
 
Conclusion 
Previous research has shown that although there is high willingness to use DCRs by Scottish 
PWID, and media representations are generally supportive, the intervention is still considered 
to be ‘controversial’, and there is a lack of national government support at UK level. We found 
that public support for DCRs may be improved by communication campaigns that clearly 
explain the potential health and economic benefits of the approach, include counter-
arguments to common concerns about DCRs, and present other benefits in relation to people 
indirectly affected by drug-related harm. 
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Table 1 Sample characteristics; * p < 0.05; 1 higher scores represent more negative attitudes 
 
 Basic 
(n= 267) 
Factual 
(n= 267) 
Factual + 
refutation 
(n= 267) 
Sympathetic 
(n= 267) 
Sympathetic + 
Factual 
(n= 268) 
Sympathetic 
+ Factual 
+ Refutation 
(n= 255) 
Differences 
between groups? 
(p value) 
All participants 
(N= 1591) 
Age 45.7  16.1 44.6  15.8  44.2  16.2 43.9  16.5 45.7  16.4 45.0  157 F5,739 = .588 (.709) 44.9  16.1 
Female (%) 51.7 50.9 50.6 47.1 49.3 52.2 25 = 1.76 (.882) 50.3 
Degree or above (%) 45.7 43.4 45.3 39.0 48.9 48.2 25 = 6.97 (.223) 45.1 
White/White British (%) 94.4 96.3 97.0 95.9 94.4 92.9 25 = 6.38 (.271) 95.2 
Employment  (%) 61.6 60.0 56.8 59.8 60.8 62.0 25 = .90 (.970) 60.1 
Voting preference (%)         
Left wing  56.2 57.3 58.9 53.8 56.3 53.3 25 = 2.90 (.715) 57.7 
Centre  6.5 7.7 5.3 6.8 4.9 8.2 25 = 3.81 (.576) 6.7 
Right wing  33.1 35.1 35.8 39.4 34.0 32.9 25 = 2.32 (.804) 35.6 
Received drug treatment - Family 
member/close friend (%) 
29.3 27.6 31.2 27.3 32.9 21.8 25 = 9.05 (.107) 28.4 
Received drug treatment - self (%) 5.3 7.5 5.6 8.0 7.5 7.2 25 = 2.59 (.762) 6.9 
Witnessed street-based injection 12.7 15.4 15.4 16.1 14.9 17.6 25 = 2.60 (.762) 15.3 
Witnessed street-based drug litter 33.3 42.7 33.3 39.0 38.4 36.5 25 = 7.45 (.189) 37.2 
Seen media report about DCR (%) 37.8 40.8 39.7 42.7 43.7 38.0 25 = 8.75 (.556) 40.5 
Supportive 37.6 36.7 34.9 33.3 45.3 39.2 25 = 4.27 (.511) 37.9 
Opposed 9.9 10.1 15.1 13.2 11.1 10.3 25 = 2.23 (.816) 11.6 
Balanced 52.5 53.2 50.0 53.5 43.6 50.5 25 = 3.14 (.679) 50.5 
Lifetime use of drugs (%)         
Amphetamines 19.2 17.7 15.0 18.7 17.3 18.9 25 = 8.44 (.586) 17.8 
Alcohol 90.2 91.0 90.6 92.9 90.6 89.0 25 = 8.09 (.620) 90.7 
Cannabis 42.3 48.1 39.1 48.1 48.5 45.1 25 = 9.18 (.515) 45.2 
Powdered cocaine 19.7 20.0 17.4 204 19.9 16.9 25 = 11.20 (.339) 19.1 
Crack cocaine 2.2 4.2 4.1 4.2 3.4 7.9 25 = 22.70 (.012*) 4.3 
MDMA/Ecstasy 19.1 19.2 12.8 18.1 17.5 20.4 25 = 15.0 (.132) 17.8 
Heroin/methadone 2.6 5.7 3.7 3.0 1.9 6.3 25 = 13.20 (.214) 3.8 
Prescription drugs 32.6 24.2 26.6 28.8 29.5 26.4 25 = 15.50 (.113) 28.0 
Self-reported prior knowledge 
about DCR (mean ± SD) 
4.4  2.8 4.5  2.7 4.4  2.8 4.8  2.5 4.6  2.8 4.9  2.7 F5,739 = 1.05 (.388) 4.6  2.7 
Self-reported knowledge about 
substance use problems (mean ± 
SD) 
5.9  2.2 5.8  2.1 5.9  2.4 5.9  2.2 6.0  2.3 6.2  2.1 F5,739 = 1.35 (.243) 5.9  2.2 
Attitudes to people who are 
homeless1  
10.3  2.6 10.5  2.5 10.3  2.5 10.7  2.3 10.4  2.5 10.2  2.4 F5,739 = 1.48 (.194) 10.4  2.5 
Attitudes to people in recovery1  61.2  14.0 61.9  14.9 61.3  13.6 62.8  13.3 61.9  14.3 60.4  12.7 F5,739 = 1.01 (.413) 61.6  13.8 
Total support for DCR score 84.1  15.4 87.2  1.2 88.5  18.7 86.5  17.4 87.3  19.3 87.4  17.5 F5,739 = 2.15 (.057) 86.8  18.1 
 34 
Table 2 Attitudes to DCR score - results of ANCOVA. F (11,1489) = 170.594, p < .001. For 
all between subjects effects F df = 1,1489 (5,1489 for message condition). * p < .05; ** p< 
.01; *** p < .001 
 
Parameter F p-value B SE 
Factors      
Message 
Condition 
5.555** .001    
Covariates      
Attitudes to 
Homelessness  
21.354*** .001 .707 .153 .096 
Attitudes to 
Recovery 
1061.353*** .001 .903 .028 .691 
Self-rated 
knowledge 
about drug use 
3.288 .070 -.309 0.170 -.038 
Self-rated 
knowledge 
about DCR 
14.594** .001 0.513 .134 .077 
Received drug 
treatment - 
Family 
member/close 
friend 
1.368 .242 -.882 0.754 -.049 
Received drug 
treatment - self 
3.710 .054 -2.541 1.319 -.141 
Contrasts (ref = 
basic) 
t (1489)     
Factual 1.958 .050 2.095 1.070 .116 
Factual + 
refutation 
3.974*** <.001 4.248 1.069 .254 
Sympathetic 0.461 .645 .495 1.074 .023 
Sympathetic + 
factual 
2.516* .012 2.705 1.075 .150 
Sympathetic + 
factual + 
refutation 
3.854*** <.001 4.182 1.085 .232 
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Table 3 Summary of hierarchical regression for variables predicting support for DCR. R2 step 1 = 
.005; R2 step 2 = .015, R2step 3 = .659, p< .001; * p < 0.05; ** p < 0.01; *** p < 0.001. 
Variable B SE   p-value 
Step 1     
Intercept 88.906 1.977  < .001 
Message Condition (ref 
= basic) 
    
Factual .176 2.789 .009 .950 
Factual + refutation 2.541 2.811 .131 .366 
Sympathetic 1.377 2.742 .071 .616 
Sympathetic + factual .697 2.706 .036 .797 
Sympathetic + factual + 
refutation 
2.116 2.851 .109 .458 
Step 2     
Intercept 82.658 3.290  < .001 
Message Condition (ref 
= basic) 
    
Factual .081 2.779 .004 .977 
Factual + refutation 2.281 2.801 .118 .416 
Sympathetic 1.260 2.742 .065 .646 
Sympathetic + factual 1.224 2.705 .063 .651 
Sympathetic + factual + 
refutation 
2.032 2.839 .105 .475 
     
Age .118* .054 .095 .030 
Gender (ref = male) .536 1.644 .028 .744 
Education (ref = degree) -1.352 1.611 -.070 .402 
Employment status (ref 
= full time) 
2.107 1.702 .109 .216 
Step 3     
Intercept 16.448 3.800  < .001 
Message Condition (ref 
= basic) 
    
Factual 2.337 1.6111 .121 .148 
Factual + refutation 5.848*** 1.628 .302 < .001 
Sympathetic .592 1.590 .031 .710 
Sympathetic + factual 1.984 1.573 .103 .208 
Sympathetic + factual + 
refutation 
5.436*** 1.653 .281 <.001 
     
Age .184*** .033 .149 <.001 
Gender (ref = male) -1.278 .964 -.067 .185 
Education (ref = degree) -.316 .952 -.016 .740 
Employment status (ref 
= full time) 
.212 .992 .011 .830 
     
Political orientation (ref 
= Left wing) 
    
Right -1.759 1.007 -.091 .081 
Centre -4.260* 2.158 -.220 .049 
Attitudes to 
Homelessness  
.614* .244 .078 .012 
Attitudes to Recovery .999*** .043 .732 <.001 
Self-reported knowledge 
about drug use 
-.760** .273 -.083 .006 
Self-reported knowledge 
about DCR 
.442 .240 .053 .066 
Received drug treatment 
- Family member/close 
friend 
-.402 1.104 -.021 .716 
Received drug treatment 
- self 
-3.164 1.687 -.164 .061 
Exposure to DCR media 
(ref = supportive) 
    
Opposed -8.249*** 1.567 -.427 <.001 
Balanced -5.441*** 1.056 -.281 <.001 
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Supplementary material 
S1 Message Elements 
 
1. Basic DCR Description  
 
Drug consumption rooms (DCRs), also known as supervised injection facilities or 
supervised consumption facilities, are designated places that legally permit the injection of 
drugs (or other forms of consumption), including those that are purchased illegally, under the 
supervision of medically-trained staff. These facilities also provide sterile injecting equipment 
(such as needles and syringes), to reduce behaviours such as syringe sharing and provide 
access to health and social care staff. Some facilities also support people to enter drug 
treatment to help them deal with their drug use. UK drug laws do not currently permit the 
operation of DCR, and therefore none are currently in operation in the UK. 
 
2. Factual information  
 
In 2017, around 2500 people died in the UK after overdosing on opioid drugs such as heroin 
– equal to about 7 people a day. This is an increase of almost 50% since 2007 when 1700 
people died. These are some of the highest number of deaths ever recorded after taking drugs, 
and is more than the 1710 people who died on UK roads in 2017. 
  
People who inject drugs are also at risk from being infected with blood-borne viruses such as 
HIV and Hepatitis C through sharing of needles and other injecting equipment like spoons and 
filters. For example, in 2015 there was a large outbreak of HIV in people in Glasgow who inject 
drugs. Over 150 people were infected, which was much higher than expected, and the vast 
majority of these people reported that they usually injected in public places, such as in 
backstreets and tenement closes, abandoned buildings, public toilets, and car parks. There 
were also other outbreaks of serious infectious diseases among people who inject drugs such 
as botulism and anthrax. People who inject in public places are at an even higher risk of drug-
related harms (including overdose and infectious diseases like blood-borne viruses) due to 
the lack of access to a clean and safe environment, including access to clean water and 
injecting equipment. 
   
Research studies have shown that DCRs are successful at attracting the most vulnerable 
people who inject drugs, including people who inject in public places, and people who are 
experiencing homelessness. 
  
Research also shows that DCRs can reduce overdose deaths in people who use the facilities, 
can promote safer injection conditions, and enhance access to health and treatment services. 
There has never been an overdose death reported in any of the international scientific studies 
that have examined DCRs. By providing a safer and more hygienic injecting environment, 
DCRs also reduce the risk of sharing needles and injecting equipment, and so could potentially 
reduce transmission of blood-borne virus and other diseases. 
  
Economists have concluded that although DCRs can be expensive to set up, they could end 
up saving the NHS and the public money in the long-term, because of the overdose deaths 
and infections that they prevent. For example, it has been estimated that a DCR costs 
approximately £2 million per year to run, but the estimated costs to society of each drug death 
are £1.6 million, and lifetime cost of treating someone with HIV ranges from £250,000 to 
£500,000. 
  
There are currently over 100 DCRs in operation across cities in Europe, Canada, and 
Australia, and some of these have been operating for more than 30 years. 
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NHS Greater Glasgow and Clyde want to open a DCR in Glasgow in order to try to reduce 
deaths and disease from injecting drug use. Other cities in the UK have also expressed 
interest in these facilities. However, UK law does not currently permit DCRs to open, as a 
number of drug-related offences are likely to be committed by allowing people to bring in and 
use illegally bought drugs onto the premises. The UK Government announced at the beginning 
of 2020 that it did not have any plans to change the law. 
 
3) Pre-emptive refutation 
 
Some people argue that we shouldn’t have DCRs. They say that these facilities encourage 
people to keep using drugs, and to keep breaking the law. They say that the best way to 
reduce death and disease from drug use is to stop people using drugs altogether. They also 
worry that the sites will attract drug users from other areas, and that drug dealing and crime 
in the neighbourhood will get worse. They are also concerned that drug litter such as the 
number of discarded needles and syringes on the street will increase. Opponents of DCRs 
have also argued that at a time when health and social services are financially stretched, it is 
wrong to spend money helping people to use illegal drugs. 
 
But in fact, DCRs provide people who use drugs with an ideal opportunity to make contact 
with drug treatment services. Research from Canada, where these facilities have been 
operating for over 15 years, show that they encourage people to enter drug detoxification 
services, often for the first time. Most people who use drugs eventually go on to successfully 
recover and stop using with the right sort of support, but they can’t recover if they’re already 
dead from an overdose. 
 
As the medical costs to care for someone living with infections such as HIV/AIDS are so high, 
by helping to prevent transmission of these infections in the first place, DCRs provide good 
value for money. Medical staff in DCRs can also provide general healthcare services, which 
can reduce later burden on the NHS. This is important for people such as those experiencing 
homelessness who may rarely be in contact with a doctor. 
 
Drug consumption rooms will always be controversial, and it is important to spend time to find 
the right location for them, but in countries where public opinion has been assessed, research 
shows that despite initial fears about the potential negative impacts on the surrounding 
community, residents and business owners become more supportive of these facilities once 
they have opened. These studies also show that there are no changes in the number of crimes 
reported in the neighbourhood, and there is no evidence to suggest that drug dealing or drug-
related litter increases. 
 
In fact, most DCRs in Europe have been established with the support of the police, who have 
worked closely with local councils, health and social services, and drug treatment charities. In 
Germany, for example, the police said that their support for the introduction of DCR didn’t 
meant they’d gone ‘soft on crime’. Instead, they welcomed the introduction as it meant drug 
scenes moved away from public ‘hot spots’ into smaller areas that could be more easily 
managed. 
 
These countries have shown that it is possible to change the law to permit DCRs as part of a 
set of wider response to the reduce harms of drug use. Drug consumption rooms are not a 
‘magic bullet’, but where they are needed, they play an important part of this wider response. 
 
4) Sympathetic narrative 
 
September 25th has become a very difficult time for Mary Paterson. That’s her son Peter’s 
birthday, who died of a heroin overdose two years ago.  
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Things began to change for Peter when he moved away from his home town to live in the city 
with his partner. Things were going well, he had a job, but had plans to go to college to 
complete a course, and he was looking forward to the future. However, his relationship with 
his partner broke down when the couple lost a child to cot death, and he became depressed. 
Following this, Peter gave up his job, but due to unemployment he was unable to afford 
somewhere to live and started begging to fund accommodation in a hostel. However, he left 
the hostel due to threats of violence and ended up sleeping rough in the city centre. It was 
then that he started smoking heroin, and within a few months, he began injecting. 
 
Peter felt ashamed and believed that he had let his family down, and so he began contacting 
them much less often. Peter’s family always loved him, but didn’t know what to do or where to 
get help for him. Like most people, Mary didn’t know anything about drugs, and when she 
found out Peter was using heroin she couldn’t believe it was happening to her son. 
 
A local charity befriended Peter on the streets and registered him with homeless health 
services, but Peter’s heroin use made it difficult for him to keep appointments. He began 
walking with a bad limp due to an unhealed infection resulting from his heroin use, and he was 
also malnourished due to a poor diet. 
 
Then in Summer 2017, Peter was found unconscious in a car park in the city centre, barely 
breathing. Despite a passer-by calling 999 it was too late, and he was pronounced dead from 
a heroin overdose. Peter was aged 29. 
 
Thinking back, Mary wonders what could have been done to help her son. She misses him 
every day, especially around his birthday. But she felt powerless to help, and anyway, before 
his death, Peter had become distant, and when he died, she didn’t even know which city he 
was in. 
 
About a year after Peter’s death, Mary learned of a national charity for families who had been 
affected by the death of a child from drugs. She got lots of support from them, and found it 
helped to talk about her son with other parents who had experienced similar losses. Through 
the charity she learned a lot more about the sorts of support that people who use drugs could 
benefit from, and to help keep them alive until they could stop their use. This included a lot of 
discussion of plans to introduce drug consumption rooms in Scotland, which had been in the 
news a lot. 
 
Whilst Mary didn’t want her son to ever have used heroin, she wished that until he was ready 
and able to stop, he could have used heroin in a place like a DCR, under the eye of a doctor 
or nurse, who could have helped in case of an emergency, and helped with his other 
healthcare needs. Instead, Peter died alone in a car park. 
 
On top of her full-time job, and in her own way, Mary now works tirelessly to prevent more 
drug overdose deaths – talking at local events to community members, and at conferences for 
doctors about her family’s experiences. She even visited her local Member of Parliament, 
asking her to argue for a change in law that would allow DCRs to open in the UK. These 
activities are always difficult for her, but she does them because she believes no parent should 
have to go through the pain of losing a child in the way she did. 
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S2 Primary outcome measure 
 
All items scored on a 5-point Likert Scale, Strongly Disagree (scored 1) to Strongly Agree 
(scored 5). R = reverse scored item. 
 
Question text: Please read the following statements and then indicate to what extent you 
agree or disagree with it. 
 
1. Drug consumption rooms will encourage safer drug injection. 
2. Drug consumption rooms will reduce overdose deaths. 
3. Drug consumption rooms will reduce infectious diseases such as HIV and 
Hepatitis C among drug users. 
4. Drug consumption rooms will increase drug users’ contact with health and 
social workers. 
5. Drug consumption rooms will reduce neighbourhood problems related to 
injecting drug use. 
6. Drug consumption rooms will increase the number of people entering drug 
treatment services. 
7. UK law should be changed to allow drug consumption rooms to open and 
operate. 
8. Access to drug consumption rooms will improve the general health of people 
who use drugs. 
9. Opening drug consumption rooms will make people think it’s legal to possess 
drugs. R 
10. Drug consumption rooms will reduce the number of people injecting in public. 
11. Drug consumption rooms will reduce the number of discarded needles and 
syringes. 
12. Drug consumption rooms will encourage people to start using drugs. R 
13. Drug consumption rooms will discourage people to stop using drugs. R 
14. Drug consumption rooms will attract drug users into an area. R 
15. Drug consumption rooms will attract drug dealers into an area. R 
16. Drug consumption rooms will lead to an increase in crime in an area. R 
17. Drug consumption rooms make drug law enforcement more difficult. R 
18. Drug consumption rooms are not a good use of public funds. R 
19. Areas that have a drug consumption room operating will be less desirable to 
live or run a business in.R 
20. It's unethical for staff working in a drug consumption room to encourage harmful 
behaviour such as the injection of drugs.R 
21. Allowing people to use drugs in a drug consumption room is a better alternative 
to dealing with drug use than arresting people. 
22. Drug consumption rooms would lead to reduced costs to the NHS by reducing 
A&E visits and hospital admissions. 
23. Opening a drug consumption room will allow the police to focus on more serious 
crimes. 
24. Drug consumption rooms create a space where people who use drugs are 
treated with dignity and respect. 
25. All things considered, I support the introduction of drug consumption rooms. 
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In principal components analysis (oblimin rotation; parallel analysis), all positively scored items 
(supportive beliefs) loaded onto a single component (Eigenvalue = 9.25, 37.0% of variance 
after rotation), and all reverse scored items (oppositional beliefs) loaded on a single 
component (Eigenvalue = 5.23, 20.9% of variance after rotation). Kaiser-Meyer-Olkin = .958, 
confirming sampling adequacy, and all KMO values for individual items were ≥ .78. Bartlett’s 
Test of Sphericity 2300 = 27016, p <.001. Factor loadings for all items were ≥ .60 and so no 
questions were deleted from the scale. 
 
Cronbach’s  for complete measure = .952 
Cronbach’s  for supportive beliefs = .952 
Cronbach’s  for oppositional beliefs = .885 
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S3 Analysis of supportive and oppositional beliefs 
 
 
Table S3.1 Supportive beliefs about DCR score - results of ANCOVA. F (11,1489) = 
43680.1, p < .001. For all between-subjects effects F df = 1,1489 (5,1489 for message 
condition). * p < .05; ** p< .01; *** p < .001 
 
Parameter F p B SE 
Factors      
Message 
Condition 
1.67 .139    
Covariates      
Attitudes to 
Homelessness  
28.79*** < .001 .436 .081 .128 
Attitudes to 
Recovery 
559.93*** <.001 .348 .015 .575 
Self-rated 
knowledge 
about drug use 
10.41*** <.001 -.292 .090 -.078 
Self-rated 
knowledge 
about DCR 
1.09 .297 .074 .071 .024 
Received drug 
treatment - 
Family 
member/close 
friend 
1.04 .307 -.409 .400 -.049 
Received drug 
treatment - self 
5.83* .016 -1.692 .701 -.203 
Contrasts (ref = 
basic) 
t (1489)     
Factual 1.52 .130 .861 .568 .103 
Factual + 
refutation 
2.43* .015 1.376 .578 .165 
Sympathetic 1.01 .315 .573 .570 .069 
Sympathetic + 
factual 
.94 .349 .534 .571 .064 
Sympathetic + 
factual + 
refutation 
.28* .023 1.315 .576 .158 
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Table S3.1 Oppositional beliefs about DCR score - results of ANCOVA. F (11,1489) = 
96.061, p < .001. For all between subjects effects F df = 1,1489 (5,1489 for message 
condition). * p < .05; ** p< .01; *** p < .001 
 
Parameter F p B SE 
Factors      
Message 
Condition 
4.75*** <.001    
Covariates      
Attitudes to 
Homelessness  
4.79* .029 .271 .124 .053 
Attitudes to 
Recovery 
611.95*** <.001 .555 .022 .603 
Self-rated 
knowledge 
about drug use 
.015 .902 -.018 .138 -.124 
Self-rated 
knowledge 
about DCR 
16.30*** <.001 .439 .109 .093 
Received drug 
treatment - 
Family 
member/close 
friend 
.60 .439 -.473 .610 -.037 
Received drug 
treatment - self 
.63 .426 -.849 1.067 -.067 
Contrasts (ref = 
basic) 
t (1489)     
Factual 1.43 .154 1.234 .866 .097 
Factual + 
refutation 
3.32*** <.001 2.871 .865 .226 
Sympathetic -.09 .929 -.078 .869 -.006 
Sympathetic + 
factual 
2.50* .013 2.171 .870 .171 
Sympathetic + 
factual + 
refutation 
3.27** .001 2.867 .878 .226 
 
 
